艾灸通过调节胆汁酸肠肝循环与肠道FXR改善克罗恩病大鼠实验性结肠炎
本研究探讨艾灸治疗克罗恩病(CD)的机制是否涉及胆汁酸(BA)肠肝循环及肠道法尼醇X受体(FXR)。将SD大鼠随机分为对照组、CD模型组、温和灸组和隔药灸组,模型采用2,4,6-三硝基苯磺酸诱导,艾灸天枢(ST25)和气海(CV6)。结果显示温和灸与隔药灸改善CD症状、抑制炎症并修复结肠黏膜损伤,其机制与调节BA肠肝循环、激活结肠FXR、调控TLR4/MyD88通路有关,隔药灸在调节BA和上调FXR方面更具优势。
要点
- 温和灸与隔药灸均可改善CD大鼠症状、抑制炎症并修复结肠黏膜。
- 艾灸作用机制涉及调节BA肠肝循环、激活FXR及抑制TLR4/MyD88通路。
- 隔药灸在调节BA肠肝循环与FXR激活方面可能更具优势。
核心结论
- 温和灸与隔药灸可通过调节BA肠肝循环稳定性、激活结肠FXR、调控TLR4/MyD88通路,抑制肠道炎症并修复肠黏膜屏障,从而改善CD。
- 隔药灸在调节BA肠肝循环和FXR激活方面似乎更具优势。
研究设计与样本
- SD大鼠随机分为对照组、CD模型组、温和灸组和隔药灸组。
- CD模型采用2,4,6-三硝基苯磺酸诱导,艾灸干预取穴天枢(ST25)和气海(CV6)。
主要发现
- 温和灸和隔药灸改善CD症状,抑制炎症并修复结肠黏膜损伤。
- 艾灸改善结肠、肝脏和血清中BA的异常表达,下调干扰素-γ表达,上调FXR mRNA表达,抑制TLR4和MyD88 mRNA表达。
- 免疫组化显示艾灸上调FXR和mucin2表达、抑制TLR4表达;Western blot显示艾灸抑制TLR4和MyD88蛋白表达、上调FXR表达。
- 免疫荧光显示艾灸增加FXR与TLR4或NF-κB p65的共定位位点和强度。
- 隔药灸在改善结肠BA、上调FXR和TLR4方面更具优势。
临床怎么用
- 本研究为动物实验,结果为艾灸治疗CD的机制探索提供参考,尚不能直接推导临床推荐。
- 隔药灸在调节BA肠肝循环和FXR激活方面可能具有优势,可供进一步临床研究参考。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: This study was conducted to explore the mechanism of intestinal inflammation and barrier repair in Crohn's disease (CD) regulated by moxibustion through bile acid (BA) enterohepatic circulation and intestinal farnesoid X receptor (FXR). METHODS: Sprague-Dawley rats were randomly divided into control group, CD model group, mild moxibustion group and herb-partitioned moxibustion group. CD model rats induced by 2,4,6-trinitrobenzene sulfonic acid were treated with mild moxibustion or herb-partitioned moxibustion at Tianshu (ST25) and Qihai (CV6). The changes in CD symptoms were rated according to the disease activity index score, the serum and colon tissues of rats were collected, and the pathological changes in colon tissues were observed via histopathology. Western blot, immunohistochemistry (IHC) and immunofluorescence were used to evaluate the improvement of moxibustion on intestinal inflammation and mucosal barrier in CD by the BA-FXR pathway. RESULTS: Mild moxibustion and herb-partitioned moxibustion improved the symptoms of CD, inhibited inflammation and repaired mucosal damage to the colon in CD rats. Meanwhile, moxibustion could improve the abnormal expression of BA in the colon, liver and serum, downregulate the expression of interferon-γ and upregulate the expression of FXR mRNA, and inhibit Toll-like receptor 4 (TLR4) and myeloid differentiation factor 88 (MyD88) mRNA. The IHC results showed that moxibustion could upregulate the expression of FXR and mucin2 and inhibit TLR4 expression. Western blot showed that moxibustion inhibited the protein expression of TLR4 and MyD88 and upregulated the expression of FXR. Immunofluorescence image analysis showed that moxibustion increased the colocalization sites and intensity of FXR with TLR4 or nuclear factor-κB p65. In particular, herb-partitioned moxibustion has more advantages in improving BA and upregulating FXR and TLR4 in the colon. CONCLUSION: Mild moxibustion and herb-partitioned moxibustion can improve CD by regulating the enterohepatic circulation stability of BA, activating colonic FXR, regulating the TLR4/MyD88 pathway, inhibiting intestinal inflammation and repairing the intestinal mucosal barrier. Herb-partitioned moxibustion seems to have more advantages in regulating BA enterohepatic circulation and FXR activation. Please cite this article as: Shen JC, Qi Q, Han D, Lu Y, Huang R, Zhu Y, Zhang LS, Qin XD, Zhang F, Wu HG, Liu HR. Moxibustion improves experimental colitis in rats with Crohn's disease by regulating bile acid enterohepatic circulation and intestinal farnesoid X receptor. J Integr Med. 2023; 21(2): 194-204.
引用
- Shen JC, Qi Q, Han D, et al. Moxibustion improves experimental colitis in rats with Crohn's disease by regulating bile acid enterohepatic circulation and intestinal farnesoid X receptor. J Integr Med. 2023. PMID: 36740466. doi:10.1016/j.joim.2023.01.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。